These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2089049)

  • 1. Stability of a novel dithranol ointment formulation, containing ascorbyl palmitate as an anti-oxidant.
    Weller PJ; Newman CM; Middleton KR; Wicker SM
    J Clin Pharm Ther; 1990 Dec; 15(6):419-23. PubMed ID: 2089049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short contact dithranol therapy: advantages of a stiff emulsifying ointment base.
    Walker GB; Harrison PV; Seville RH; Smith JF
    Br J Dermatol; 1989 Feb; 120(2):277-83. PubMed ID: 2647124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
    Marriott PJ; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():101-6. PubMed ID: 1268069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-contact modification of the Ingram regime.
    Ryatt KS; Statham BN; Rowell NR
    Br J Dermatol; 1984 Oct; 111(4):455-9. PubMed ID: 6487547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthralin stability in various vehicles.
    Green PG; Kennedy CT; Forbes DR
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):984-8. PubMed ID: 3584582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of active chronic psoriasis: a comparison of the effectiveness of a preparation containing 0.1% dithranol and 17% urea in a cream base and 0.1% dithranol in Lassar's past B.P.C.
    Portnoy B; Beck MH
    Acta Derm Venereol; 1981; 61(5):459-61. PubMed ID: 6172945
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis.
    Fredriksson T
    Pharmatherapeutica; 1983; 3(7):496-8. PubMed ID: 6366807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified dithranol treatment for psoriasis.
    Seville RH
    Br J Dermatol; 1975 Aug; 93(2):205-8. PubMed ID: 1100095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ascorbyl palmitate in topical microemulsions.
    Spiclin P; Gasperlin M; Kmetec V
    Int J Pharm; 2001 Jul; 222(2):271-9. PubMed ID: 11427357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the therapeutic effect of dithranol cream 0.1% and 0.25% with that of dithranol stylus 0.1% and 0.2% in the treatment of psoriasis.
    Gisslèn H; Nordin P
    J Int Med Res; 1983; 11(1):46-50. PubMed ID: 6832465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stability of cignolin (dithranol) in ointments containing tar with and without the addition of salicylic acid. Oxidation to danthron and dithranol dimer].
    Müller R; Naumann E; Detmar M; Orfanos CE
    Hautarzt; 1987 Feb; 38(2):107-11. PubMed ID: 3570777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
    Göransson A
    Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of vitamin C derivatives in topical formulations containing lipoic acid, vitamins A and E.
    Segall AI; Moyano MA
    Int J Cosmet Sci; 2008 Dec; 30(6):453-8. PubMed ID: 19099546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach for increasing ascorbyl palmitate stability by addition of non-irritant co-antioxidant.
    Gosenca M; Obreza A; Pečar S; Gašperlin M
    AAPS PharmSciTech; 2010 Sep; 11(3):1485-92. PubMed ID: 20845090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriasis with dithranol cream compared with dithranol paste.
    Young E
    Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis.
    Grattan CE; Christopher AP; Robinson M; Cowan MA
    Br J Dermatol; 1988 Nov; 119(5):623-6. PubMed ID: 3061441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation and antioxidant activity of ascorbyl palmitate with maize starch during pasting.
    Bamidele OP; Duodu KG; Emmambux MN
    Carbohydr Polym; 2017 Jun; 166():202-208. PubMed ID: 28385224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.